logo
#

Latest news with #NB.1.8.1

Corona cases jump 1300% in 9 days, 21 deaths in just..., active cases surge to...
Corona cases jump 1300% in 9 days, 21 deaths in just..., active cases surge to...

India.com

time7 hours ago

  • Health
  • India.com

Corona cases jump 1300% in 9 days, 21 deaths in just..., active cases surge to...

File/Representational Corona cases: Amid the latest wave of Covid-19, the number of SARS-CoV2 infections in the country has risen to 3783, rising at a rate of 1372 % in the last nine days. As many as 511 new cases were recorded from the previous day, according to the latest update by the Health Ministry on Saturday. Meanwhile, 255 patients were discharged or migrated in the last 24 hours, indicating an improvement in recovery. According to the website of the Health Department, there were 257 cases in India on May 22. As per the data, Kerala has the highest number of cases at 1400. Maharashtra has 485 active cases and Delhi has 436 active cases. There have been 28 deaths due to corona since January. Out of these, 21 people have died in the last 2 days. Kerala with 1,147 cases is the worst-hit state, followed by Maharashtra (424), Delhi (294), and Gujarat (223). The highest number of deaths have been reported from Maharashtra (7), followed by Kerala (5), and Delhi (2). Meanwhile, 255 patients were discharged or migrated in the last 24 hours, indicating an improvement in recovery. The cumulative number of recovered cases since January 1 stands at 1,170. Kerala (72), Delhi (77), and Maharashtra (34) contributed the highest number of recoveries on the day. As per the latest data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), set up under the Ministry of Health and Family Welfare, NB.1.8.1 and LF.7 — descendants of JN.1 Covid variant in the country –are responsible for the rise in SARS-CoV-2 cases in the country. Common symptoms associated with these variants include fever, runny nose, sore throat, headaches, fatigue, and exhaustion. Recently, Dr. Rajiv Bahl, Director General at the Indian Council of Medical Research (ICMR) assured the country that there is nothing to worry about as the infections are not severe. (With inputs from agencies)

New Covid variant 'under monitoring' after spike in cases and hospitalisations
New Covid variant 'under monitoring' after spike in cases and hospitalisations

Daily Mirror

timea day ago

  • Health
  • Daily Mirror

New Covid variant 'under monitoring' after spike in cases and hospitalisations

First identified in January, NB. 1.8.1 is spreading quickly across multiple countries, leading to an increase in cases and hospitalisations, the World Health Organisation said A new coronavirus variant has been labelled as "under monitoring" by the World Health Organisation following a spike in cases and hospitalisations. First identified on January 22 2025, NB. 1.8.1 is a derivative of the Omicron strain. The variant is causing concern among health experts after being identified in multiple countries including popular holiday destinations like Egypt, Thailand and the Maldives. ‌ The WHO has warned that the new strain is now responsible for more than 10 per cent of all infections and is already the dominant strain in Hong Kong and China. The Centre of Disease Control (CDC) in the US has also identified cases in a number of states including New York, California, Arizona, Ohio, Washington, and Rhode Island. ‌ Despite saying that the variant is currently being monitored, WHO said in their report that the current risk to the public is deemed to be low - and currently approved vaccines are expected to "remain effective to this variant against symptomatic and severe disease." WHO said that despite an increase in cases and hospitalisations, currently there is no indication that this variant leads to more severe illness than other variants in circulation. Even though NB.1.8.1 has been found in popular holiday destinations, the WHO says there is no need for travel or trade restrictions at this time, Wales Online reports. The organisation urges countries to stay alert and adjust their responses as needed, but does not recommend closing borders or limiting travel. ‌ The official report states: "WHO recommends that countries remain vigilant, adapt to evolving epidemiological trends, and leverage Covid-19 management strategies to strengthen systems for all respiratory disease threats. Member States should continue offering Covid-19 vaccines in line with WHO recommendations." Health experts at the CDC say that symptoms may vary in accordance with the variant, however they will likely be similar to the typical symptoms of Covid-19. These include fever or chills, cough, shortness of breath or difficulty breathing, sore throat, congestion or runny nose, new loss of taste or smell, fatigue, muscle or body aches, headache, nausea or vomiting, diarrhoea. This week, Lara Herrero Associate Professor and Research Leader in Virology and Infectious Disease at Griffith University, said that thanks to multiple mutations, the new strain "may infect cells more efficiently than earlier strains." Professor Herrero explained: "It's possible a person infected with NB.1.8.1 may be more likely to pass the virus on to someone else, compared to earlier variants. The evidence so far suggests NB.1.8.1 may spread more easily and may partially sidestep immunity from prior infections or vaccination. These factors could explain its rise in sequencing data. "But importantly, the WHO has not yet observed any evidence it causes more severe disease compared to other variants. Reports suggest symptoms of NB.1.8.1 should align closely with other Omicron subvariants. Common symptoms include sore throat, fatigue, fever, mild cough, muscle aches and nasal congestion. Gastrointestinal symptoms may also occur in some cases." The WHO report reads: "SARS-CoV-2 continues to evolve, and between January and May 2025, there were shifts in global SARS-CoV-2 variant dynamics. At the beginning of the year, the most prevalent variant tracked by WHO at the global level was XEC, followed by KP.3.1.1. In February, circulation of XEC began to decline while that of LP.8.1 increased, with the latter becoming the most detected variant in mid-March. Since mid-April, the circulation of LP.8.1 has been slightly declining as NB.1.8.1 is increasingly being detected."

Coronavirus cases update: Highly contagious COVID-19 variant NB.1.8.1 spreads to US after China...; know its symptoms
Coronavirus cases update: Highly contagious COVID-19 variant NB.1.8.1 spreads to US after China...; know its symptoms

India.com

timea day ago

  • Health
  • India.com

Coronavirus cases update: Highly contagious COVID-19 variant NB.1.8.1 spreads to US after China...; know its symptoms

File/Representational India's Covid-19 tally has reached 2,710 active cases, with 1,170 patients discharged, as per the Union Health Ministry. The country reported seven deaths across multiple states, with comorbidities playing a significant role in most cases, according to state-wise data. According to the Health Ministry, in Delhi, one death was reported–a 60-year-old female with acute intestinal obstruction post-laparotomy, where Covid-19 was an incidental finding. While COVID-19 has once again made an entry into its headlines, a new COVID-19 variant called NB.1.8.1, which first emerged in China, is now spreading across the United States. Cases have been detected in states including New York, California, Washington, and Virginia. While it initially spread through international travelers, the variant is now spreading within local communities as well. According to the World Health Organization (WHO), NB.1.8.1 has been designated a SARS-CoV-2 variant under monitoring (VUM) with increasing proportions globally, while LP.8.1 is starting to decline. Considering the available evidence, the additional public health risk posed by NB.1.8.1 is evaluated as low at the global level. However, hospital admissions have risen in China, Hong Kong, and Taiwan. The U.S. Centers for Disease Control and Prevention (CDC) is actively monitoring the situation. According to a TIME report, information from GISAID, a global platform that tracks the genetic makeup of major disease-causing viruses, indicates that the earliest detected cases of the NB.1.8.1 variant emerged in late April. These cases were identified in travelers from countries including China, France, Japan, the Netherlands, Spain, South Korea, Taiwan, and Thailand. NB.1.8.1 has become the leading COVID-19 variant in China, where it is linked to a noticeable rise in emergency room visits and hospital admissions. According to the TIME report, the symptoms of NB.1.8.1 closely resemble those of previous COVID-19 variants, including sore throat, fever, cough, and fatigue. So far, reports from countries where the variant has emerged suggest it doesn't cause more severe illness. However, its genetic makeup includes mutations that enhance its ability to infect human cells, potentially making it more transmissible. According to a statement from the U.S. Centers for Disease Control and Prevention (CDC), a COVID-19 variant known as NB.1.8.1 is driving a rise in infections in China. Recently, a few cases were also detected in the United States among international travelers who tested positive at airports. The World Health Organization has classified this strain as a 'variant under monitoring.' The CDC runs a surveillance program at select U.S. airports where consenting travelers are randomly tested for COVID-19. This initiative first detected the NB.1.8.1 variant in late March. Since then, cases have emerged in several states, including California, Hawaii, New York, Ohio, Rhode Island, Virginia, and Washington. However, the number of confirmed cases in the U.S. remains low, and the variant has not yet appeared on the CDC's official variant tracking dashboard.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store